Women's Health Initiative Hormone Therapy Trials: New insights on Cardiovascular Disease from Additional Years of Follow up

about

Sex hormone therapy and progression of cardiovascular disease in menopausal women Could personalized management of menopause based on genomics become a reality?

P2860

Q37651567-5AB0788A-7966-4B2E-9930-BDA72E798F10 Q51346588-A18F5CB6-F497-4651-A01B-144D905FAA07

P2860

Women's Health Initiative Hormone Therapy Trials: New insights on Cardiovascular Disease from Additional Years of Follow up

Item

http://www.wikidata.org/entity/Q36839180

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Women's Health Initiative Horm ...... Additional Years of Follow up

@en

type

Item

label

Women's Health Initiative Horm ...... Additional Years of Follow up

@en

prefLabel

Women's Health Initiative Horm ...... Additional Years of Follow up

@en

P1476

Women's Health Initiative Horm ...... Additional Years of Follow up

@en

P2093

Joann E Manson

http://www.w3.org/2001/XMLSchema#string

Virginia M Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylactic oophorectomy in premenopausal women and long-term health

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Circulating microparticles: pathophysiology and clinical implications.

The 2012 hormone therapy position statement of: The North American Menopause Society.

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

P2888

s12170-013-0305-1

P304

196-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12170-013-0305-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236916772

http://www.w3.org/2001/XMLSchema#string

P698

23682305

http://www.w3.org/2001/XMLSchema#string

P932

3652473

http://www.w3.org/2001/XMLSchema#string

Women's Health Initiative Hormone Therapy Trials: New insights on Cardiovascular Disease from Additional Years of Follow up

about

P2860

P2860

Women's Health Initiative Hormone Therapy Trials: New insights on Cardiovascular Disease from Additional Years of Follow up

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932